Navigation Links
Geography has impact on grapevine moth's success in French vineyards
Date:1/8/2014

'Location, location, location' is an adage also true for the European grapevine moth, it seems. Research led by Fanny Vogelweith of the Universit de Bourgogne and INRA Bordeaux-Aquitaine in France has shown that these pests are better adapted and more successful in certain French wine-growing regions than in others, because of the variety of grape on which they occur and the abundance of their natural enemies around them. The findings were published in Springer's journal Naturwissenschaften The Science of Nature.

The European grapevine moth (Lobesia botrana) is a major grape pest in Europe because of its wide geographical distribution. The damage caused when its larvae feed on grape berries makes infection by pathogenic fungi, including the grey and black mold, easier. This leads to losses suffered by farmers.

To further understand the moth, Vogelweith's team assessed how the immune variation of its wild populations is influenced by its host plants and natural enemies. This is an important factor, as the maintenance of the immune system is generally a costly affair for most organisms and can inhibit growth and spread.

The research team therefore collected and measured larvae from up to five grape varieties from vineyards in six French viticulture regions, namely Alsace, Aquitaine, Bourgogne, Champagne-Ardenne, Rhne-Alpes, and Provence-Alpes-Cte d'Azur. Parasites found on these larvae were also collected and analyzed.

The researchers found a marked geographical variation in the immune defense and the level of parasitism among natural populations of the grapevine moth. The more parasites found in a vineyard, the higher the investment in immune defense rather than body growth. This suggests that immune defense is metabolically expensive.

Larvae sampled in the southern area from the Chardonnay, Pinot Gris, and Pinot Noir varieties tended to have a greater number of immune-related hemocyte cells and a hig
'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1 2

Related biology news :

1. Gesture Recognition & Touchless Sensing Market (2013 - 2018): By Technology, Product, Application and Geography
2. Research and Markets Announces the Release of Multi-Factor Authentication Market - by Model/Type [Two, Three, Four & Five-Factor], Application & Geography - Forecasts (2012 - 2017)
3. Researchers say fructose does not impact emerging indicator for cardiovascular disease
4. Telecoupling science shows Chinas forest sustainability packs global impact
5. Deepwater Horizon NRDA study shows possible oil impact on dolphins
6. High levels of maternal care has life-long impact on vulnerability to stress
7. New report calls for attention to abrupt impacts from climate change
8. UCSB researcher shows microplastic transfers chemicals, impacting health
9. Large study shows pollution impact on coral reefs -- and offers solution
10. Aging impacts epigenome in human skeletal muscle
11. Nurture impacts nature: Experiences leave genetic mark on brain, behavior
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
(Date:2/5/2015)... RESEARCH TRIANGLE PARK, N.C. , Feb. 5, 2015 ... as a specialist logistics company and has launched a ... industry,s only Clinical Logistics Organization (CLO).  The new campaign ... with emphasis on patient, protocol and shipments. ... Patient First , aligns Marken,s priorities with its ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... of the European corn borer has saved Midwest farmers billions ... in Science . Research conducted by several Midwest ... billion for corn growers in Illinois, Minnesota, and Wisconsin over ... this total benefiting non-Bt corn growers. Comparable estimates for Iowa ...
... Conn.A team of Yale University scientists has engineered the ... into incorporating foreign small molecules and embedding them within ... the journal ACS Chemical Biology this week, ... wall of a pathogenic "Gram-positive" bacteriaorganisms responsible not only ...
... States seeks to lessen its reliance on foreign oil, ... the National Renewable Energy Laboratory, a branch of the ... and could someday supply 3 percent to 5 percent ... to achieving that goal is figuring how to efficiently ...
Cached Biology News:Transgenic corn suppresses European corn borer, saves farmers billions 2Scientists trick bacteria with small molecules 2Brown University chemists simplify biodiesel conversion 2Brown University chemists simplify biodiesel conversion 3
(Date:3/4/2015)... 4, 2015  BioClinica®, Inc., a leading ... today announced that clinical trial professionals representing ... its annual European User Conference in ... the use of its eClinical technologies to ... include: the Microsoft Office-Smart OnPoint CTMS; Express ...
(Date:3/4/2015)... 2015 Launched by the ... in December 2011, ,SARAH, - the French ... versus sorafenib in advanced hepatocellular carcinoma (HCC) has enrolled ... SARAH, a large French study of patients ... HCC) has completed patient enrolment, exceeding its 400-patient target, ...
(Date:3/3/2015)... and TORONTO, March 3, 2015 /PRNewswire/ - Aptose Biosciences ... new therapeutics and molecular diagnostics that target the underlying ... quarter and seventh-month period ended December 31, 2014. ... fiscal year end from May 31 to December 31. ... are reporting today are for the quarter and the ...
(Date:3/3/2015)... March 03, 2015 Experts and industry ... for one event: the Alltech REBELation exploring innovation, inspiration ... 17-20. Now in its 31st year, Alltech’s annual international ... countries, and the opportunity to join the REBELation at ... at 11:59 p.m. EST, at which point the standard ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... Md., Dec. 5 Micromet, Inc. (Nasdaq:,MITI), a ... antibody-based products for cancer, inflammation and autoimmune,diseases, today ... Officer of Micromet, will be part of a ... Therapies For Cancer" at the 2007,RBC Capital Markets ...
... $8.1 Million Financing in Connection ... Reverse Stock Split Planned for January 2008, ... today announced that the Company has:, - Signed an agreement ... based in Israel. The acquisition,is expected to close tomorrow. The initial ...
... (AMEX: IMM ) announced today that the ... SA (Euronext Paris - ticker code BIO) to,commercialize ... the treatment of pneumocystis pneumonia (PCP) in AIDS ... also known as,African sleeping sickness. Pafuramidine is currently ...
Cached Biology Technology:Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007 2Amarin Signs Agreement to Acquire Ester Neurosciences 2Amarin Signs Agreement to Acquire Ester Neurosciences 3Amarin Signs Agreement to Acquire Ester Neurosciences 4Amarin Signs Agreement to Acquire Ester Neurosciences 5Amarin Signs Agreement to Acquire Ester Neurosciences 6Amarin Signs Agreement to Acquire Ester Neurosciences 7Amarin Signs Agreement to Acquire Ester Neurosciences 8Amarin Signs Agreement to Acquire Ester Neurosciences 9Amarin Signs Agreement to Acquire Ester Neurosciences 10Amarin Signs Agreement to Acquire Ester Neurosciences 11Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 3Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 4
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Normal serum collected from healthy Kunming mice....
Biology Products: